1 / 4

The Reason Behind Poor Performance Of Kids Covid Vaccines

Parents waited quite long for kids' covid vaccines. They are caught up in anticipation of which covid Vaccine is best for their kids...

Télécharger la présentation

The Reason Behind Poor Performance Of Kids Covid Vaccines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. TheReasonBehindPoorPerformance OfKidsCovidVaccines Parentswaitedquitelongforkids'covidvaccines.Theyarecaughtup inanticipationofwhichcovidVaccineisbestfortheirkids.AmidstthestruggletogetafreecovidvaccinenearmecameOmicron.The COVIDvaccines'weregiveninagebracketsbecausetheshotswere designedaccordingtoaperson'sage.Thus,kids'vaccineswereoflow dosesenoughtorenderprotectionagainstCOVID-19. InAmerica,theonlycovidVaccineavailableforKidsisfromPfizer. However,with emergingcasesofOmicron,researchersobserved dropsinprotectionfromCOVID-19,especiallyinkidswhoreceive thelowdose.EventhecovidstatsofModerna,whichwasonitsway togettingapprovalforkids'Vaccines,blockedOmicronsymptoms only40percentofthetime. Toddler'sCOVIDVaccine COVIDvaccinesforinfantsandtoddlersareexpectedtodebutbythe startofthesummeraftertheFDAandCDCofficialsgivenods.Buttheexpectationfromthesefreecovidvaccinenearmeisrelatively low.AccordingtoStephanieLangel,animmunologistfromDuke Universityandmotherofa1.8-year-oldSon,thecovidVaccinefor infantsandtoddlersmaynotreceivemuchresponse.Thecaseshave decreased,andOmicronhasspreadthewordthatoriginalshotswon't providethesameimmunityastheydidforCOVID-19.Thus,itwillbehardtodecidewhethertheinfantsandtoddlersshouldtakethefree covidVaccinenearmeornot. RegulatoryClearancefor Kids'CovidVaccines TheregulatoryclearanceofKids'COVIDvaccinestookadifferent pathforapproval.Researchersinjectedmanyadultswiththeshots whentheywereuntestedandcollectedcovidstatstoknowwhofell ill.However,kids'didnotfallsickasseverelyasadultsthroughout

  2. thepandemic.Thus,collectingefficientdataforthemwouldneeda verylongandextensivestudy. TheFDAallowedvaccinemakerstooptforanalternativecalled immunobridgingtoavoidanyfurtherdelayinrollingoutkids'covid Vaccines.Researcherssearchforadultsin whomtheVaccineis workingefficientlyanddeterminetheirimmuneresponsesinthis method.Theythencoaxtheretrievedresultswithanothersetof populations,hereKids. BuddyCreech,aVanderbiltUniversityMedicalCenter'spediatric- infectious-diseasespecialist,saystheprocessistrickierthanitlooks. Themostcrucialconcerninthecaseofkids'immunizationissafety. Theshotswithmorevaccinesmaycausemoresideeffects.Hence,the companieswentforthesmallestpossibleeffectivedoseforKids. AfterexperimentingwithdifferentamountsofmRNA,Pfizerslashed thequantitiesbyone-third.Theirdosescontained30microgramsfor 12yearsandolder,tenmicrogramsfor5to11yearsold,andthree microgramsforkidsunderfiveyears.On theotherhand,Moderna dividedthedosageintohalvesbygiving100microgramstoeveryone abovetwelve,50microgramsto kidsbetween6 and11 years,and25 microgramstokidsunder6. ResultsofCovidVaccinesinKids Thecompaniesranlargetrialsfortheinformationonantibodydata requiredforpresentingtotheFDAandmonitoringfor worseside effects.Boththecompaniesshowedthattheymetsafetycriteria. Accordingto theirpublicstatements,thefeverratewasatparwith otherkids'vaccines.Buttheantibodyrealmtoldadifferentstory. Pfizer'stwodosesof30gramswereinefficientinthekidsofagegroup2-4years.Thus,thecompanywouldhavetoaddathirdshotfor kidsyoungerthanfiveyears. Ontheotherhand,Moderna'stwodosesof25microgramsforkids undersixshowedresultssimilartothoseinadults.Ifcreating antibodieswastheanswer,thenModernawouldhaverolledoutthe infantandtoddlercovidvaccinebynow. Instead,whenModernawas still runningtrialsforKids'CovidVaccines,Omicroninfectedmany

  3. kidsenrolledinthestudy.Itgavethecompanyenoughdatato calculatetheVaccine'sperformance.However,accordingtosome officials,thisiswheretheshotsstartedtofallshort. AccordingtoFDA,avaccineshouldeitherpreventdiseaseor decreasethedisease'sseveritybyatleast50percent.TheVaccine gavepromisedresultsinadults,butthedatafromkids'covidstats studybarelygraspedatit.However,ChandyJohn,apediatricianat IndianaUniversity,suggestedthatevena40percentprotectionin InfantsandToddlerswouldbeexcellent. TheBlameGame Poorresultsstartedablamegame.Everyoneblamedsomeorthe otherthingbasedontheiropinion. ThemostblamedreasonwasthequantityofmRNAforKids.Alittle moremRNAwouldhavegivenknock-outresultsforModerna. AuthoritiesraisedthesameconcernsaboutPfizer'sVaccinethatcould notprotectthekids5to11yearsof agefromCOVID-19fora requiredtime.ThoughPfizer'sVaccinehadmetitsimmunobridging benchmarkinclinicaltrials,thequantityofmRNAwasn'tenoughto providestrikingresultslikeinadults. AnotherprominentreasonbehindVaccine'spoorresultsisthevirus itself.Thevirusmutated,whereastheKidsvaccinewasmadefrom theoriginalrecipe.Therefore,twodosesoffreecovidVaccinenear meforKidswouldnothaverendereddesiredresults.Furthermore, duringOmicronspread,thevaccinationinadultsshowedonly40 percentefficacy,andtoreach50,theywouldrequireanextrashot. Thus,itisundoubtedlydifficulttogetresultsinKidswithsuchalow mRNAlevel. Conclusion Today,whichcovidVaccineisbestforKidsischallengingto answer.ThoughModernacontainsmoremRNA,itisnotefficient enough.Moreover,increasingmRNAamountcanleadtosevereside effectsthataredifficulttohandleinthecaseofkids.Thecovid stats

  4. suggestthatkidsrequiremoreantibodylevelscomparedtoadults. However,gettingmorelevelsofantibodieswouldrequireahighdose ofmRNA,whichinturncanhaveseveresideeffectsinchildren. Hence,itisbettertogetashotandstayalittlesaferatherthan fightingblindlywiththedisease.

More Related